However, TCGA data suggest that mRNA expression of DYRK2 is higher in breast invasive carcinoma and that higher DYRK2 expression correlates with poor survival in overall patients with breast cancer (8, 10, 26). Here, DYRK2 is linked to invasive breast carcinoma.